Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
3.820
-0.080 (-2.05%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Neuphoria Therapeutics Employees
As of June 30, 2025, Neuphoria Therapeutics had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,178,892
Market Cap
20.65M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 8 | 0 | - | 7 | 1 |
| Jun 30, 2024 | 8 | - | - | 8 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Celularity | 115 |
| NextCure | 40 |
| Daré Bioscience | 24 |
| Jasper Therapeutics | 22 |
| Quantum BioPharma | 17 |
| Atossa Therapeutics | 16 |
| Cellectar Biosciences | 11 |
NEUP News
- 16 days ago - Neuphoria Therapeutics Proxy statement: Proxy filing - Filings
- 17 days ago - Neuphoria Therapeutics to be acquired by Scancell - TheFly
- 17 days ago - Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing - GlobeNewsWire
- 6 weeks ago - Neuphoria Therapeutics confirms merger discussions with Scancell Holdings - TheFly
- 6 weeks ago - Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc - GlobeNewsWire
- 3 months ago - Neuphoria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 3 months ago - Neuphoria Therapeutics Quarterly report: Q3 2026 - Filings
- 6 months ago - Neuphoria Therapeutics Quarterly report: Q2 2026 - Filings